Nation's healthcare shines in global spotlight

Vast market catches eye of drug and medical device makers

It was a significant moment for world healthcare when two global pharmaceutical companies looked to China as the first country for approval of a new drug - bypassing the United States and European nations.

In December, the National Medical Products Administration approved Roxadustat, a drug developed by AstraZeneca and FibroGen, as a new treatment for anemia caused by chronic kidney disease in patients dependent on dialysis.